{"id":"NCT00736853","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"An Efficacy and Safety Study of Acetaminophen Plus Tramadol Hydrochloride (JNS013) in Participants With Chronic Pain","officialTitle":"A Phase 3 Study of JNS013 in Patients With Chronic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2009-01","completion":"2009-01","firstPosted":"2008-08-18","resultsPosted":"2013-09-26","lastUpdate":"2013-09-26"},"enrollment":321,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Tramadol Hydrochloride Plus Acetaminophen (Open-Label)","otherNames":[]},{"type":"DRUG","name":"Tramadol Hydrochloride Plus Acetaminophen (Double-Blind)","otherNames":[]},{"type":"DRUG","name":"Placebo (Double-Blind)","otherNames":[]}],"arms":[{"label":"Tramadol Hydrochloride Plus Acetaminophen (Open-Label)","type":"EXPERIMENTAL"},{"label":"Tramadol Hydrochloride Plus Acetaminophen (Double Blind)","type":"EXPERIMENTAL"},{"label":"Placebo (Double-Blind)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of tramadol hydrochloride plus acetaminophen (JNS013) in participants with chronic pain accompanied by osteoarthritis (a progressive and degenerative joint disease, in which the joints become painful and stiff) of the knee or low back pain (acute or chronic pain in the lumbar or sacral regions) which cannot be controlled sufficiently with non-steriodal anti-inflammatory drugs (NSAIDs).","primaryOutcome":{"measure":"Number of Participants With Insufficient Pain Relief After the Start of Double-Blind Period","timeFrame":"Day 28 of double-blind period","effectByArm":[{"arm":"Tramadol Hydrochloride and Acetaminophen (Double-Blind)","deltaMin":20,"sd":null},{"arm":"Placebo (Double-Blind)","deltaMin":43,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":20,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=423&filename=CR015112_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":277},"commonTop":["Nausea","Somnolence","Vomiting","Constipation","Dizziness"]}}